Evidence map›Paper›PMID 38205041›Full record

ArticleUrology case reports2024

Primary embryonal carcinoma of the prostate.

Milan Radovanović, Aleksa Zubelić, Veljko Šantrić, Uroš Babić, Nebojša Prijović, Predrag Nikić

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Urology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Milan RadovanovićUniversity Clinical Centre of Serbia, Clinic of Urology, Belgrade, Serbia.
Aleksa ZubelićDepartment of Urology, Varisano-Klinik, Bad Soden, Germany.
Veljko ŠantrićUniversity Clinical Centre of Serbia, Clinic of Urology, Belgrade, Serbia.
Uroš BabićUniversity Clinical Centre of Serbia, Clinic of Urology, Belgrade, Serbia.
Nebojša PrijovićUniversity Clinical Centre of Serbia, Clinic of Urology, Belgrade, Serbia.
Predrag NikićUniversity Clinical Centre of Serbia, Clinic of Urology, Belgrade, Serbia.
Univerzitetski Klinički Centar Srbije · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extragonadal germ cell tumors originating in the prostate are extremely rare. Thus far, less than 20 cases were described in the literature. To our knowledge, there are no published cases of primary embryonal carcinoma of the prostate. The present study presents a case of a 24-year-old male with primary prostate embryonal carcinoma. The patient received cisplatin-based chemotherapy. The patient refused a surgical treatment, which resulted in relapse of the disease and death in a short follow-up period. The present case shows that primary embryonal carcinoma may also be found in prostate and indicates the potential importance of timely surgical resection.

Indexed as

Embryonal carcinomaGerm cell tumorProstate

Identifiers

PMID38205041
PMCPMC10776437
OpenAlexW4389858000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.